{"cik":1124105,"taxonomy":"us-gaap","tag":"LongTermDebt","label":"Long-term Debt","description":"Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.","entityName":"Gyre Therapeutics, Inc.","units":{"USD":[{"end":"2012-12-31","val":1987000,"accn":"0001193125-13-109464","fy":2012,"fp":"FY","form":"10-K","filed":"2013-03-15","frame":"CY2012Q4I"},{"end":"2013-12-31","val":1136000,"accn":"0001193125-14-099974","fy":2013,"fp":"FY","form":"10-K","filed":"2014-03-14","frame":"CY2013Q4I"},{"end":"2014-12-31","val":0,"accn":"0001193125-15-093871","fy":2014,"fp":"FY","form":"10-K","filed":"2015-03-16","frame":"CY2014Q4I"}]}}